A minimum of 3 months of dietary fish oil supplementation is required to raise amygdaloid afterdischarge seizure thresholds in rats - implications for treating complex partial seizures

Epilepsy and Behavior

Volumn 27, Issue 1, 2013, Pages 49-58

  Taha, Ameer Y ^a   Trepanier, Marc Olivier ^a,b   Ciobanu, Flaviu A ^a   Taha, Nadeen M ^a,b   Ahmed, Muaz ^a   Zeng, Qiudi ^a   Cheuk, Waiyin I ^a   Ip, Bryan ^a   Filo, Elvis ^a   Scott, Brian W ^a   Burnham, W M ^a   Bazinet, Richard P ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Afterdischarge seizure threshold; Amygdala; Complex partial; Docosahexaenoic acid (DHA); Drug resistant; Eicosapentanoic acid (EPA); Epilepsy; Fish oil; Omega 3 Polyunsaturated fatty acids (PUFAs); Seizures

Indexed keywords

DOCOSAHEXAENOIC ACID; FISH OIL; ICOSAPENTAENOIC ACID; OLEIC ACID; OMEGA 3 FATTY ACID; PENTETRAZOLE;

AFTERDISCHARGE; AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COMPLEX PARTIAL SEIZURE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOSE RESPONSE; LIPID COMPOSITION; MALE; NONHUMAN; PYRIFORM CORTEX; RAT; SEIZURE THRESHOLD;

EID: 84873120924     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2012.12.004     Document Type: Article

References (65)

1. Theodore W.H., Spencer S.S., Wiebe S., et al. Epilepsy in North America: a report prepared under the auspices of the global campaign against epilepsy, the International Bureau for Epilepsy, the International League Against Epilepsy, and the World Health Organization. Epilepsia 2006, 47:1700-1722.
2. O'Donoghue M.F., Goodridge D.M., Redhead K., Sander J.W., Duncan J.S. Assessing the psychosocial consequences of epilepsy: a community-based study. Br J Gen Pract 1999, 49:211-214.
3. Hauser W.A., Annegers J.F., Elveback L.R. Mortality in patients with epilepsy. Epilepsia 1980, 21:399-412.
4. Kloster R., Engelskjon T. Sudden unexpected death in epilepsy (SUDEP): a clinical perspective and a search for risk factors. J Neurol Neurosurg Psychiatry 1999, 67:439-444.
5. Opeskin K., Harvey A.S., Cordner S.M., Berkovic S.F. Sudden unexpected death in epilepsy in Victoria. J Clin Neurosci 2000, 7:34-37.
6. Racoosin J.A. Mortality in epilepsy: searching for clues in populations and patients. Neurology 2003, 60:363-364.
7. Sperling M.R., Harris A., Nei M., Liporace J.D., O'Connor M.J. Mortality after epilepsy surgery. Epilepsia 2005, 46(Suppl. 11):49-53.
8. Stephen L.J., Kwan P., Brodie M.J. Does the cause of localisation-related epilepsy influence the response to antiepileptic drug treatment?. Epilepsia 2001, 42:357-362.
9. Oles K.S., Penry J.K., Cole D.L., Howard G. Use of acetazolamide as an adjunct to carbamazepine in refractory partial seizures. Epilepsia 1989, 30:74-78.
10. Albright P.S. Effects of carbamazepine, clonazepam, and phenytoin on seizure threshold in amygdala and cortex. Exp Neurol 1983, 79:11-17.
11. Albright P.S., Burnham W.M. Development of a new pharmacological seizure model: effects of anticonvulsants on cortical- and amygdala-kindled seizures in the rat. Epilepsia 1980, 21:681-689.
12. Cunnane S.C., Musa K., Ryan M.A., Whiting S., Fraser D.D. Potential role of polyunsaturates in seizure protection achieved with the ketogenic diet. Prostaglandins Leukot Essent Fatty Acids 2002, 67:131-135.
13. Yuen A.W., Sander J.W. Is omega-3 fatty acid deficiency a factor contributing to refractory seizures and SUDEP? A hypothesis. Seizure 2004, 13:104-107.
14. Gilby K.L., Jans J., McIntyre D.C. Chronic omega-3 supplementation in seizure-prone versus seizure-resistant rat strains: a cautionary tale. Neuroscience 2009, 163:750-758.
15. Taha A.Y., Huot P.S., Reza-Lopez S., et al. Seizure resistance in fat-1 transgenic mice endogenously synthesizing high levels of omega-3 polyunsaturated fatty acids. J Neurochem 2008, 105:380-388.
16. Chen C.C., Chaung H.C., Chung M.Y., Huang L.T. Menhaden fish oil improves spatial memory in rat pups following recurrent pentylenetetrazole-induced seizures. Epilepsy Behav 2006, 8:516-521.
17. Willis S., Samala R., Rosenberger T.A., Borges K. Eicosapentaenoic and docosahexaenoic acids are not anticonvulsant or neuroprotective in acute mouse seizure models. Epilepsia 2009, 50:138-142.
18. Curatolo N., Lecointe C., Bordet R., et al. Oral administration of docosahexaenoic acid/eicosapentaeinoic acids is not anticonvulsant in rats: implications for translational research. Pediatr Res 2011, 70:584-588.
19. Matthews H., Granger N., Wood J., Skelly B. Effects of essential fatty acid supplementation in dogs with idiopathic epilepsy: a clinical trial. Vet J 2012, 191:396-398.
20. Chen C.T., Ma D.W., Kim J.H., Mount H.T., Bazinet R.P. The low density lipoprotein receptor is not necessary for maintaining mouse brain polyunsaturated fatty acid concentrations. J Lipid Res 2008, 49:147-152.
21. Rahman T., Taha A.Y., Song B.J., et al. The very low density lipoprotein receptor is not necessary for maintaining brain polyunsaturated fatty acid concentrations. Prostaglandins Leukot Essent Fatty Acids 2010, 82:141-145.
22. Robinson P.J., Noronha J., DeGeorge J.J., Freed L.M., Nariai T., Rapoport S.I. A quantitative method for measuring regional in vivo fatty-acid incorporation into and turnover within brain phospholipids: review and critical analysis. Brain Res Brain Res Rev 1992, 17:187-214.
23. Song B.J., Elbert A., Rahman T., et al. Genetic ablation of CD36 does not alter mouse brain polyunsaturated fatty acid concentrations. Lipids 2010, 45:291-299.
24. Fisher R.S. Animal models of the epilepsies. Brain Res Brain Res Rev 1989, 14:245-278.
25. Racine R.J. Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencephalogr Clin Neurophysiol 1972, 32:281-294.
26. Folch J., Lees M., Sloane Stanley G.H. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 1957, 226:497-509.
27. Taha A.Y., Jeffrey M.A., Taha N.M., Bala S., Burnham W.M. Acute administration of docosahexaenoic acid increases resistance to pentylenetetrazol-induced seizures in rats. Epilepsy Behav 2010, 17:336-343.
28. Trepanier M.O., Taha A.Y., Mantha R.L., et al. Increases in seizure latencies induced by subcutaneous docosahexaenoic acid are lost at higher doses. Epilepsy Res 2012, 99:225-232.
29. Racine R.J. Modification of seizure activity by electrical stimulation I. After-discharge threshold. Electroencephalogr Clin Neurophysiol 1972, 32:269-279.
30. Ng M.S., Hwang P., Burnham W.M. Afterdischarge threshold reduction in the kindling model of epilepsy. Epilepsy Res 2006, 72:97-101.
31. Musto A.E., Gjorstrup P., Bazan N.G. The omega-3 fatty acid-derived neuroprotectin D1 limits hippocampal hyperexcitability and seizure susceptibility in kindling epileptogenesis. Epilepsia 2011, 52:1601-1608.
32. Pages N., Maurois P., Delplanque B., et al. Brain protection by rapeseed oil in magnesium-deficient mice. Prostaglandins Leukot Essent Fatty Acids 2011, 85:53-60.
33. Porta N., Bourgois B., Galabert C., et al. Anticonvulsant effects of linolenic acid are unrelated to brain phospholipid cell membrane compositions. Epilepsia 2009, 50:65-71.
34. Rabinovitz S., Mostofsky D.I., Yehuda S. Anticonvulsant efficiency, behavioral performance and cortisol levels: a comparison of carbamazepine (CBZ) and a fatty acid compound (SR-3). Psychoneuroendocrinology 2004, 29:113-124.
35. Taha A.Y., Filo E., Ma D.W., McIntyre Burnham W. Dose-dependent anticonvulsant effects of linoleic and alpha-linolenic polyunsaturated fatty acids on pentylenetetrazol induced seizures in rats. Epilepsia 2009, 50:72-82.
36. Voskuyl R.A., Vreugdenhil M., Kang J.X., Leaf A. Anticonvulsant effect of polyunsaturated fatty acids in rats, using the cortical stimulation model. Eur J Pharmacol 1998, 341:145-152.
37. Yehuda S., Carasso R.L., Mostofsky D.I. Essential fatty acid preparation (SR-3) raises the seizure threshold in rats. Eur J Pharmacol 1994, 254:193-198.
38. Pages N., Maurois P., Delplanque B., Bac P., Vamecq J. Brain anticonvulsant protection of mice given chronic carbamazepine under various fatty acid and magnesium diet conditions. Prostaglandins Leukot Essent Fatty Acids 2012, 87:63-70.
39. Tanna I.R., Aghera H.B., Ashok B.K., Chandola H.M. Protective role of Ashwagandharishta and flax seed oil against maximal electroshock induced seizures in albino rats. Ayub 2012, 33:114-118.
40. Brodie M.J. Management strategies for refractory localization-related seizures. Epilepsia 2001, 42(Suppl. 3):27-30.
41. Macdonald R.L., Barker J.L. Pentylenetetrazol and penicillin are selective antagonists of GABA-mediated post-synaptic inhibition in cultured mammalian neurones. Nature 1977, 267:720-721.
42. Ouellet M., Emond V., Chen C.T., et al. Diffusion of docosahexaenoic and eicosapentaenoic acids through the blood-brain barrier: an in situ cerebral perfusion study. Neurochem Int 2009, 55:476-482.
43. Chen C.T., Green J.T., Orr S.K., Bazinet R.P. Regulation of brain polyunsaturated fatty acid uptake and turnover. Prostaglandins Leukot Essent Fatty Acids 2008, 79:85-91.
44. Connor S., Tenorio G., Clandinin M.T., Sauve Y. DHA supplementation enhances high-frequency, stimulation-induced synaptic transmission in mouse hippocampus. Appl Physiol Nutr Metab 2012, 37:880-887.
45. Rachetti A.L., Arida R.M., Patti C.L., et al. Fish oil supplementation and physical exercise program: distinct effects on different memory tasks. Behav Brain Res 2012, 237C:283-289.
46. Meldrum B.S., Brierley J.B. Neuronal loss and gliosis in the hippocampus following repetitive epileptic seizures induced in adolescent baboons by allylglycine. Brain Res 1972, 48:361-365.
47. Dam A.M. Epilepsy and neuron loss in the hippocampus. Epilepsia 1980, 21:617-629.
48. Vreugdenhil M., Bruehl C., Voskuyl R.A., Kang J.X., Leaf A., Wadman W.J. Polyunsaturated fatty acids modulate sodium and calcium currents in CA1 neurons. Proc Natl Acad Sci U S A 1996, 93:12559-12563.
49. Xiao Y.F., Gomez A.M., Morgan J.P., Lederer W.J., Leaf A. Suppression of voltage-gated L-type Ca2+ currents by polyunsaturated fatty acids in adult and neonatal rat ventricular myocytes. Proc Natl Acad Sci U S A 1997, 94:4182-4187.
50. Xiao Y., Li X. Polyunsaturated fatty acids modify mouse hippocampal neuronal excitability during excitotoxic or convulsant stimulation. Brain Res 1999, 846:112-121.
51. Willis S., Samala R., Rosenberger T.A., Borges K. Eicosapentaenoic and docosahexaenoic acids are not anticonvulsant or neuroprotective in acute mouse seizure models. Epilepsia 2009, 50:138-142.
52. Bromfield E., Dworetzky B., Hurwitz S., et al. A randomized trial of polyunsaturated fatty acids for refractory epilepsy. Epilepsy Behav 2008, 12:187-190.
53. DeGiorgio C.M., Miller P., Meymandi S., Gornbein J.A. n-3 fatty acids (fish oil) for epilepsy, cardiac risk factors, and risk of SUDEP: clues from a pilot, double-blind, exploratory study. Epilepsy Behav 2008, 13:681-684.
54. Yuen A.W., Sander J.W., Fluegel D., et al. Omega-3 fatty acid supplementation in patients with chronic epilepsy: a randomized trial. Epilepsy Behav 2005, 7:253-258.
55. DeMar J.C., Ma K., Bell J.M., Rapoport S.I. Half-lives of docosahexaenoic acid in rat brain phospholipids are prolonged by 15weeks of nutritional deprivation of n-3 polyunsaturated fatty acids. J Neurochem 2004, 91:1125-1137.
56. Umhau J.C., Zhou W., Carson R.E., et al. Imaging incorporation of circulating docosahexaenoic acid into the human brain using positron emission tomography. J Lipid Res 2009, 50:1259-1268.
57. Schlanger S., Shinitzky M., Yam D. Diet enriched with omega-3 fatty acids alleviates convulsion symptoms in epilepsy patients. Epilepsia 2002, 43:103-104.
58. Al Khayat H.A., Awadallah M.M., Al Wakad A., Marzook Z.A. Polyunsaturated fatty acids in children with idiopathic intractable epilepsy: serum levels and therapeutic response. J Pediatr Neurol 2010, 8:175-185.
59. Krall R.L., Penry J.K., White B.G., Kupferberg H.J., Swinyard E.A. Antiepileptic drug development: II. Anticonvulsant drug screening. Epilepsia 1978, 19:409-428.
60. McNamara J.O., Rigsbee L.C., Butler L.S., Shin C. Intravenous phenytoin is an effective anticonvulsant in the kindling model. Ann Neurol 1989, 26:675-678.
61. Chen C.T., Liu Z., Ouellet M., Calon F., Bazinet R.P. Rapid beta-oxidation of eicosapentaenoic acid in mouse brain: an in situ study. Prostaglandins Leukot Essent Fatty Acids 2009, 80:157-163.
62. Chen C.T., Liu Z., Bazinet R.P. Rapid de-esterification and loss of eicosapentaenoic acid from rat brain phospholipids: an intracerebroventricular study. J Neurochem 2011, 116:363-373.
63. Young C., Gean P.W., Chiou L.C., Shen Y.Z. Docosahexaenoic acid inhibits synaptic transmission and epileptiform activity in the rat hippocampus. Synapse 2000, 37:90-94.
64. El-Mowafy A.M., Abdel-Dayem M.A., Abdel-Aziz A., El-Azab M.F., Said S.A. Eicosapentaenoic acid ablates valproate-induced liver oxidative stress and cellular derangement without altering its clearance rate: dynamic synergy and therapeutic utility. Biochim Biophys Acta 2011, 1811:460-467.
65. Yuen A.W., Flugel D., Poepel A., Bell G.S., Peacock J.L., Sander J.W. Non-randomized open trial of eicosapentaenoic acid (EPA), an omega-3 fatty acid, in ten people with chronic epilepsy. Epilepsy Behav 2012, 23:370-372.